PAR paradigm biopharmaceuticals limited..

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-14

  1. 479 Posts.
    lightbulb Created with Sketch. 121
    lol no point back and forth,but bugger it they have had interest like we have said and PR just stated no business model will front up coin without confirmation and some more certainty from the regulatory bodies,what dont you people understand about that. Deals have been discussed obviously in the past,organisations have shown interest maybe some are confused by deals and interest.
    Or just sad about when you decided to press the buy button,this is understandable given the opportunity to buy in now i would be pissed with myself aswell.
    Then throw in the the back and forth from the FDA etc then you have delays simple shit really but anyways go your hardest im sure you all will find some way to crack the sads again.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.3¢
Change
-0.003(0.79%)
Mkt cap ! $123.2M
Open High Low Value Volume
31.0¢ 32.0¢ 30.8¢ $147.2K 470.4K

Buyers (Bids)

No. Vol. Price($)
4 24193 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 34044 8
View Market Depth
Last trade - 15.00pm 11/08/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.